Is complete remission key in elderly patients with AML? [electronic resource]
- The Lancet. Haematology May 2016
- e212-3 p. digital
Publication Type: Journal Article
2352-3026
10.1016/S2352-3026(15)00285-9 doi
Aged Aged, 80 and over Antineoplastic Agents--adverse effects Comparative Effectiveness Research Disease Progression Humans Leukemia, Myeloid, Acute--mortality Quality of Life Remission Induction Survival Analysis